Drug Profile
Staphylococcus aureus vaccine - GlaxoSmithKline
Alternative Names: GSK 2392102ALatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Bacterial vaccines; Conjugate vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Staphylococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Staphylococcal-infections(In volunteers) in Belgium (IM, Injection)